Market news

Medtronic's 49-Year Dividend Streak Faces a New Challenge: Is Growth Finally the Real Story? Medtro...

Medtronic's 49-Year Dividend Streak Faces a New Challenge: Is Growth Finally the Real Story? Medtronic has raised its dividend for 49 straight years while the stock quietly lost a fifth of its value, but something in the operating room just changed the entire conversation about why investors should own it.

QATS is not a registered broker-dealer or investment advisor. All strategies are created and managed by users. Trading involves risk, and past performance is not indicative of future results. QATS does not store or manage user funds. All trades are executed via official broker APIs. Users must be 18 years or older to use the platform.

Maurizio Vitalle 3

© 2026 Quant Algorithm Tree System Ltd.

A better experience starts with cookies

Your data, your choice. We use cookies to improve how things work here.

Cookie policy